|
213. |
Bernstein, J. A.*, Maurer, M.*, and Saini, S. S.+*: BTK signaling – a crucial link in the pathophysiology of chronic spontaneous urticaria. J. Allergy Clin. Immunol. 2024: 153; 1229-1240. IF: TBD (IF 2023: 11.40) |
r.213
BTK signaling – a crucial link in the pathophysiology of chronic spontaneous urticaria Read More »
|
212. |
Elieh-Ali-Komi, D., Bot, I., Rodríguez-González, M., and Maurer, M.+: Cellular and molecular mechanisms of mast cells in atherosclerotic plaque progression and destabilization. Clin. Rev. Allergy Immunol. 2024: 66; 30-49. IF: TBD (IF 2023: 8.40) |
r.212
|
211. |
Kolkhir, P.+, Altrichter, S., Badloe, F. M., Belasn, H., Charles, N., De Vriese, S., Gutermuth, J., Huygen, L., Kocatürk, E., Kortekaas Krohn, I., Muñoz, M., Moñino-Romero, S., Reber, L. L., Scheffel, J., Steinert, C., Xiang, Y.-K., and Maurer, M.: The European network for IgE-mediated autoimmunity and autoallergy (ENIGMA) initiative. Nat. Med. 2024: 30; 920-922. IF: TBD (IF 2023: 58.70) |
r.211
The European network for IgE-mediated autoimmunity and autoallergy (ENIGMA) initiative Read More »
|
210. |
Metz, M., Kolkhir, P., Altrichter, S., Siebenhaar, F., Levi-Schaffer, F., Youngblood, B. A., Church, M. K., and Maurer, M.+: Mast cell silencing: a novel therapeutic approach for urticaria and other mast cell-mediated diseases. Allergy 2023: 79; 37-51. IF: 12.60 |
r.210
|
209. |
Zuberbier, T.+, Stevanovic, K., Ansotegui, I. J., Anto, J. M., Bergmann, K.-C., D’Amato, G., Grüntuch-Ernst, A., Haahtela, T., Maurer, M., Pietikäinen, S., Christou, D., and Bousquet, J.: Green roof gardens – selecting allergy friendly vegetation: a GA²LEN position paper. J. Allergy Clin. Immunol. Pract. 2023: 12; 347-354. IF: 8.20 |
r.209
Green roof gardens – selecting allergy friendly vegetation: a GA²LEN position paper Read More »
|
208. |
Hu, M., Scheffel, J., Elieh-Ali-Komi, D., Maurer, M., Hawro, T.+, and Metz, M.+: An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma. Clin. Exp. Med. 2023: 23; 4177-4197. IF: 3.20 |
r.208
|
207. |
Kocatürk, E.+, Abrams, E. M., Maurer, M., Mitri, J., Oppenheimer, J., Vestergaard, C., and Zein, J.: COVID-19 and its impact on common diseases in the allergy clinics. J. Allergy Clin. Immunol. Pract. 2023: 11; 3289-3303. IF: 8.20 |
r.207
COVID-19 and its impact on common diseases in the allergy clinics Read More »
|
206. |
Casale, T. B.+, Giménez-Arnau, A. M., Bernstein, J. A., Holden, M., Zuberbier, T., and Maurer, M.: Omalizumab for patients with chronic spontaneous urticaria: a narrative review of current status. Dermatol. Ther. 2023: 13; 2573-2588. IF: 3.50 |
r.206
|
205. |
Charles, N.+, Kortekaas Krohn, I., Kocatürk, E., Scheffel, J., Altrichter, S., Steinert, C., Xiang, Y.-K., Gutermuth, J., Reber, L., and Maurer, M.*: Autoreactive IgE: pathogenic role and therapeutic target in autoimmune diseases. Allergy 2023: 78; 3118-3135. IF: 12.60 |
r.205
Autoreactive IgE: pathogenic role and therapeutic target in autoimmune diseases Read More »
|
204. |
Asero, R.+*, Ferrer, M.*, Kocatürk, E.*, and Maurer, M.*: Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity and autoallergy. J. Allergy Clin. Immunol. Pract. 2023: 11; 2302-2308. IF: 8.20 |
r.204